Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Acorda Therapeutics (ACOR)

Acorda Therapeutics (ACOR)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 39,763
  • Shares Outstanding, K 9,490
  • Annual Sales, $ 152,970 K
  • Annual Income, $ -99,590 K
  • 60-Month Beta 0.60
  • Price/Sales 0.28
  • Price/Cash Flow N/A
  • Price/Book 0.14
Trade ACOR with:

Options Overview

Details
  • Implied Volatility 108.25%
  • Historical Volatility 50.38%
  • IV Percentile 0%
  • IV Rank 0.40%
  • IV High 662.62% on 06/05/20
  • IV Low 106.01% on 03/17/21
  • Put/Call Vol Ratio 2.33
  • Today's Volume 50
  • Volume Avg (30-Day) 180
  • Put/Call OI Ratio 0.38
  • Today's Open Interest 9,602
  • Open Int (30-Day) 2,952

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 2 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/21
See More
  • Average Estimate -3.71
  • Number of Estimates 1
  • High Estimate -3.71
  • Low Estimate -3.71
  • Prior Year -0.84
  • Growth Rate Est. (year over year) -341.67%

Price Performance

See More
Period Period Low Period High Performance
1-Month
3.91 +6.39%
on 04/12/21
6.08 -31.58%
on 03/18/21
-1.70 (-29.01%)
since 03/12/21
3-Month
3.91 +6.39%
on 04/12/21
8.66 -51.96%
on 01/20/21
-1.96 (-32.03%)
since 01/13/21
52-Week
2.53 +64.14%
on 09/14/20
9.84 -57.72%
on 10/20/20
-2.32 (-35.80%)
since 04/13/20

Most Recent Stories

More News
Celebrity Chef Zarela Martinez Partners with Acorda Therapeutics on the launch of "A Taste for Life with Zarela(SM)"

Culinary icon Zarela Martinez and Acorda Therapeutics (NASDAQ: ACOR) have partnered to launch "A Taste for Life with Zarela" to celebrate Parkinson's Awareness Month. The video series showcases Zarela's...

ACOR : 4.16 (+1.96%)
QIAGEN's (QGEN) NeuMoDx Multiplex Test Receives FDA EUA

QIAGEN's (QGEN) new NeuMoDx Flu A-B/RSV/SARS-CoV-2 Vantage test strengthens the company's portfolio in PCR testing, while becoming a crucial diagnostic tool for the flu season and the pandemic.

ACOR : 4.16 (+1.96%)
QGEN : 52.03 (+0.87%)
CDMO : 19.24 (+1.64%)
ARPO : 1.2500 (-1.57%)
Tandem (TNDM) Grows on Abbott, Dexcom Pacts Amid COVID-19 Woes

Tandem Diabetes (TNDM) is expects t:sport to be a major growth catalyst for 2022.

ACOR : 4.16 (+1.96%)
TNDM : 87.99 (+0.34%)
AVIR : 57.22 (+3.45%)
CDMO : 19.24 (+1.64%)
Illumina's (ILMN) Expanded NIPT Coverage Study Outcome Favorable

Illumina's (ILMN) coverage for pregnant women under the age of 35 will provide access of NIPT to thousands of women with minimal financial impact.

ILMN : 403.15 (+1.04%)
ACOR : 4.16 (+1.96%)
AVIR : 57.22 (+3.45%)
CDMO : 19.24 (+1.64%)
Vertex (VRTX) Type I Diabetes Candidate Clinical Study Begins

Vertex (VRTX) begins early-stage clinical study on cellular therapy, VX-880 for type-I diabetes. FDA also grants Fast Track status to the candidate.

ACOR : 4.16 (+1.96%)
MRNA : 149.71 (+7.40%)
VRTX : 215.94 (+1.10%)
CRSP : 120.88 (+5.67%)
Has Acorda Therapeutics (ACOR) Outpaced Other Medical Stocks This Year?

Is (ACOR) Outperforming Other Medical Stocks This Year?

ACOR : 4.16 (+1.96%)
Acorda Therapeutics to Present at H.C. Wainwright Global Life Sciences Virtual Conference

Acorda Therapeutics, Inc. (NASDAQ: ACOR) announced that Ron Cohen, M.D., President and Chief Executive Officer, will present during the March 9th & 10th H.C. Wainwright Global Life Sciences Virtual Conference....

ACOR : 4.16 (+1.96%)
Illumina (ILMN) NGS-Based Platform Approved for Use in Russia

Illumina and R-Pharm's in-vitro diagnostics platform registration will drive the expansion of Next Generation Sequencing-based clinical diagnostics across Russia.

ILMN : 403.15 (+1.04%)
ACOR : 4.16 (+1.96%)
CLSD : 2.63 (-5.73%)
AVIR : 57.22 (+3.45%)
QIAGEN (QGEN) Unveils Digital Platform for Syndromic Testing

QIAGEN's (QGEN) QIAsphere cloud-based platform will enhance QIAstat-Dx's potential by offering remote services round the clock to improve testing continuity.

ACOR : 4.16 (+1.96%)
QGEN : 52.03 (+0.87%)
CLSD : 2.63 (-5.73%)
AVIR : 57.22 (+3.45%)
Acorda Therapeutics (ACOR) Reports Q4 Loss, Tops Revenue Estimates

Acorda (ACOR) delivered earnings and revenue surprises of -68.92% and 12.24%, respectively, for the quarter ended December 2020. Do the numbers hold clues to what lies ahead for the stock?

ACOR : 4.16 (+1.96%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 24% Sell with a Weakening short term outlook on maintaining the current direction.

The market is in highly oversold territory. Beware of a trend reversal.

See More Share

Business Summary

Acorda Therapeutics, Inc. is a biotechnology company developing and commercializing neurology therapies for Parkinson's disease, migraine and multiple sclerosis. Acorda has a pipeline of novel neurological therapies addressing a range of disorders, including Parkinson's disease and multiple sclerosis....

See More

Key Turning Points

3rd Resistance Point 4.39
2nd Resistance Point 4.27
1st Resistance Point 4.22
Last Price 4.16
1st Support Level 4.05
2nd Support Level 3.93
3rd Support Level 3.88

See More

52-Week High 9.84
Fibonacci 61.8% 7.05
Fibonacci 50% 6.19
Fibonacci 38.2% 5.33
Last Price 4.16
52-Week Low 2.53

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar